Purchases and Sales Made in Q3 2023 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q3 2023. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Two Seas Capital LP
Rye, NY |
SELL
|
- |
-67.4K- 29.02% |
$358K - $740K
|
165K
$2.33M
|
|
|
Nov 09, 2023
Q3 2023
|
Ubs Group Ag
|
SELL
|
- |
-75.6K- 54.1% |
$401K - $830K
|
64.1K
$905K
|
|
|
Nov 13, 2023
Q3 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-80.6K- 16.13% |
$428K - $885K
|
419K
$5.92M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-81KClosed |
$430K - $890K
|
0
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Alpha Centric Advisors LLC
San Juan, PR |
SELL
|
- |
-128K- 43.59% |
$677K - $1.4M
|
165K
$2.33M
|
|
|
Nov 14, 2023
Q3 2023
|
Weiss Multi Strategy Advisers LLC
New York, NY |
SELL
|
- |
-195K- 72.5% |
$1.04M - $2.14M
|
74K
$1.04M
|
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-211K- 4.99% |
$1.12M - $2.32M
|
4.02M
$56.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-235K- 16.35% |
$1.25M - $2.59M
|
1.2M
$17M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-264K- 54.31% |
$1.4M - $2.9M
|
222K
$3.13M
|
|
|
Nov 13, 2023
Q3 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-360K- 21.8% |
$1.91M - $3.95M
|
1.29M
$18.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-361K- 52.04% |
$1.92M - $3.97M
|
333K
$4.7M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-400K- 54.57% |
$2.12M - $4.39M
|
333K
$4.7M
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-865K- 16.56% |
$4.59M - $9.5M
|
4.36M
$61.5M
|